RxDoctor Payments Data

Robert Liu

Physician Assistant · Loma Linda, CANPI 1578135760

Payments from drug & device makers

$5,893in general payments, 2019–2025

Across 29 payments — averaging $203.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$5K
  • GSK$288
  • Pulmonx Corporation$264
  • Merck$150
  • Verona Pharma, Inc.$125
  • Boston Scientific$88
  • plus $121 from 3 others

What the payments were for

  • Consulting fees$2,53243%
  • Travel & lodging$1,57527%
  • Food & beverage$1,78630%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,893 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$90,842
Medicare patients
388
Services billed
1,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter401$275,328
Spiriva RespimatTiotropium Bromide164$115,936
Dupixent PenDupilumab26$94,681
XolairOmalizumab26$86,491
Breo ElliptaFluticasone/Vilanterol159$73,123
EliquisApixaban84$67,518
Stiolto RespimatTiotropium Br/Olodaterol Hcl85$51,126
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr76$35,828
SymbicortBudesonide/Formoterol Fumarate101$25,441
Advair HfaFluticasone Propion/Salmeterol61$25,216
Albuterol Sulfate HfaAlbuterol Sulfate489$19,733
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$18,442
XareltoRivaroxaban22$17,903
Spiriva HandihalerTiotropium Bromide18$16,596
Incruse ElliptaUmeclidinium Bromide38$13,883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$288$398,163674 claims
MerckDulera$150$8,61622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →